![Laurence Rulleau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Laurence Rulleau
Presidente presso Find Therapeutics
Profilo
Laurence Rulleau is currently a Director at DalCor Pharmaceuticals Canada, Inc., PreciThera, Inc., adMare Bioinnovations, and Find Therapeutics.
Additionally, Dr. Rulleau is the President & Director at Find Therapeutics.
Prior to these current positions, Dr. Rulleau was a Managing Partner at CTI Capital, Inc. Dr. Rulleau has also held positions as a Director at Neomed Institute and as an Analyst at Blackmont Capital Securities.
Dr. Rulleau holds a doctorate degree from the University of Montréal and a graduate degree from Université du Québec à Montréal.
Posizioni attive di Laurence Rulleau
Società | Posizione | Inizio |
---|---|---|
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - |
adMare Bioinnovations
![]() adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | - |
CTI Capital, Inc.
![]() CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Investitore di Private Equity | 01/11/2014 |
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Presidente | - |
PreciThera, Inc.
![]() PreciThera, Inc. Pharmaceuticals: MajorHealth Technology Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Laurence Rulleau
Società | Posizione | Fine |
---|---|---|
Blackmont Capital Securities
![]() Blackmont Capital Securities Investment Banks/BrokersFinance Blackmont Capital Securities is the broker subsidiary of Blackmont Capital, Inc. They focus on sectors such as energy, metals and minerals, biotechnology and health services, technology and special situations, business trusts and industrials, consumer staples, real estate and hospitality and financial services. Blackmont screens for emerging influences, shifts in market dynamics and changes in corporate fundamentals to identify immediate growth opportunities with the best risk-reward profile | Analyst-Equity | 02/10/2007 |
Neomed Institute
![]() Neomed Institute Pharmaceuticals: OtherHealth Technology Neomed Institute operated as a non-profit organization for pharmaceutical companies. It offered analytical services, drug development, licensing, and drug discovery. The company was founded in 2012 and was headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - |
Formazione di Laurence Rulleau
University of Montréal | Doctorate Degree |
Université du Québec à Montréal | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 7 |
---|---|
Blackmont Capital Securities
![]() Blackmont Capital Securities Investment Banks/BrokersFinance Blackmont Capital Securities is the broker subsidiary of Blackmont Capital, Inc. They focus on sectors such as energy, metals and minerals, biotechnology and health services, technology and special situations, business trusts and industrials, consumer staples, real estate and hospitality and financial services. Blackmont screens for emerging influences, shifts in market dynamics and changes in corporate fundamentals to identify immediate growth opportunities with the best risk-reward profile | Finance |
DalCor Pharmaceuticals Canada, Inc.
![]() DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Health Technology |
Neomed Institute
![]() Neomed Institute Pharmaceuticals: OtherHealth Technology Neomed Institute operated as a non-profit organization for pharmaceutical companies. It offered analytical services, drug development, licensing, and drug discovery. The company was founded in 2012 and was headquartered in Montreal, Canada. | Health Technology |
adMare Bioinnovations
![]() adMare Bioinnovations adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | |
CTI Capital, Inc.
![]() CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Finance |
Find Therapeutics
![]() Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Health Technology |
PreciThera, Inc.
![]() PreciThera, Inc. Pharmaceuticals: MajorHealth Technology Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada. | Health Technology |
- Borsa valori
- Insiders
- Laurence Rulleau